Cohen I M, O'Connor D T, Preston R A, Stone R A
Clin Pharmacol Ther. 1979 Nov;26(5):572-7. doi: 10.1002/cpt1979265572.
The antihypertensive effect of clonidine has been attributed to acute inhibition of sympathetic outflow from the central nervous system. This conclusion is derived from experiments with single doses of clonidine. The mechanism of the long-term blood pressure-lowering effect of clonidine has been less well characterized. Antihypertensive therapy may alter renal hemodynamics and these changes may ultimately affect systemic blood pressure. We studied the effect of long-term clonidine therapy on intrarenal hemodynamics, the renin-angiotensin system, and selected indices of sympathetic nervous system activity in 13 patients with essential hypertension to further elucidate its action. Long-term clonidine therapy resulted in decreased MAP and RVR associated with the suppression of supine but not upright PRA. RPF, RBF, FF, and WBV did not change. UKA, on index of the the putative vasodilating renal kallikrein-kinin system, was also not changed. Our findings suggest a role for PRA in modulating RVR during long-term clonidine therapy. This was associated with the reduction observed in MAP.
可乐定的降压作用归因于对中枢神经系统交感神经输出的急性抑制。这一结论源自单次剂量可乐定的实验。可乐定长期降压作用的机制尚未得到充分阐明。抗高血压治疗可能会改变肾血流动力学,而这些变化最终可能影响全身血压。我们研究了长期可乐定治疗对13例原发性高血压患者肾内血流动力学、肾素 - 血管紧张素系统以及交感神经系统活动选定指标的影响,以进一步阐明其作用机制。长期可乐定治疗导致平均动脉压(MAP)和肾血管阻力(RVR)降低,同时仰卧位血浆肾素活性(PRA)受到抑制,但直立位PRA未受抑制。肾血浆流量(RPF)、肾血流量(RBF)、滤过分数(FF)和全身血容量(WBV)均未改变。尿激肽原酶(UKA)作为推测的血管舒张性肾激肽 - 激肽系统的一个指标,也未改变。我们的研究结果表明,在长期可乐定治疗期间,PRA在调节RVR方面发挥作用,这与MAP的降低有关。